Rehmann Capital Advisory Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,298
Closed -$456K 620
2025
Q1
$456K Sell
6,298
-19
-0.3% -$1.38K 0.03% 377
2024
Q4
$468K Sell
6,317
-629
-9% -$46.6K 0.03% 370
2024
Q3
$458K Sell
6,946
-904
-12% -$59.7K 0.03% 361
2024
Q2
$725K Sell
7,850
-221
-3% -$20.4K 0.05% 254
2024
Q1
$771K Sell
8,071
-112
-1% -$10.7K 0.06% 236
2023
Q4
$624K Sell
8,183
-875
-10% -$66.7K 0.05% 264
2023
Q3
$628K Buy
+9,058
New +$628K 0.06% 256
2023
Q2
Sell
-9,940
Closed -$822K 557
2023
Q1
$822K Sell
9,940
-114
-1% -$9.43K 0.08% 219
2022
Q4
$750K Buy
10,054
+313
+3% +$23.4K 0.08% 223
2022
Q3
$805K Buy
9,741
+106
+1% +$8.76K 0.09% 196
2022
Q2
$916K Buy
9,635
+564
+6% +$53.6K 0.1% 172
2022
Q1
$1.07M Buy
9,071
+46
+0.5% +$5.42K 0.1% 179
2021
Q4
$1.17M Sell
9,025
-867
-9% -$112K 0.11% 174
2021
Q3
$1.12M Sell
9,892
-151
-2% -$17.1K 0.11% 173
2021
Q2
$1.04M Buy
10,043
+90
+0.9% +$9.32K 0.1% 175
2021
Q1
$832K Buy
9,953
+245
+3% +$20.5K 0.09% 198
2020
Q4
$886K Sell
9,708
-36
-0.4% -$3.28K 0.1% 172
2020
Q3
$778K Buy
9,744
+17
+0.2% +$1.36K 0.1% 178
2020
Q2
$672K Buy
9,727
+217
+2% +$15K 0.09% 187
2020
Q1
$598K Buy
+9,510
New +$598K 0.1% 173
2019
Q3
$672K Sell
9,171
-51
-0.6% -$3.74K 0.08% 133
2019
Q2
$568K Sell
9,222
-54
-0.6% -$3.33K 0.07% 226
2019
Q1
$592K Buy
9,276
+48
+0.5% +$3.06K 0.08% 192
2018
Q4
$471K Buy
9,228
+18
+0.2% +$919 0.07% 141
2018
Q3
$534K Buy
9,210
+15
+0.2% +$870 0.07% 206
2018
Q2
$446K Sell
9,195
-96
-1% -$4.66K 0.06% 228
2018
Q1
$432K Hold
9,291
0.07% 214
2017
Q4
$349K Buy
9,291
+294
+3% +$11K 0.06% 251
2017
Q3
$328K Buy
8,997
+2,328
+35% +$84.9K 0.06% 244
2017
Q2
$263K Sell
6,669
-3,510
-34% -$138K 0.05% 286
2017
Q1
$319K Buy
10,179
+165
+2% +$5.17K 0.05% 258
2016
Q4
$313K Buy
10,014
+1,308
+15% +$40.9K 0.06% 260
2016
Q3
$350K Buy
8,706
+927
+12% +$37.3K 0.07% 227
2016
Q2
$259K Sell
7,779
-261
-3% -$8.69K 0.05% 290
2016
Q1
$236K Sell
8,040
-384
-5% -$11.3K 0.05% 295
2015
Q4
$222K Buy
+8,424
New +$222K 0.05% 305